Appointment of Secretarial Auditor
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd's Board of Directors, at a meeting held on 30th May 2025, approved the appointment of Mr. Amit Anand, a Practicing Company Secretary, as the Secretarial Auditor of the Company. Mr. Amit Anand is an Associate Member of ICSI with experience in company law, SEBI regulations, and compliance management. The appointment is for a period of five consecutive years, covering FY 2025-26 to FY 2029-2030, and is subject to shareholder approval at the upcoming Annual General Meeting. This is a routine regulatory compliance appointment under Section 204(1) of the Companies Act, 2013.
This is a standard compliance-related appointment and is unlikely to have any material impact on the stock price or shareholders. It simply ensures the Company meets its statutory secretarial audit requirements over the next five years.